<DOC>
	<DOCNO>NCT01655589</DOCNO>
	<brief_summary>The main purpose study investigate association VEGF gene polymorphism response intravitreal drug neovascular age-related macular degeneration . This retrospective review patient treat 2008 2012 Institute Vision , Belo Horizonte , Brazil .</brief_summary>
	<brief_title>VEGF Gene Association With Response Neovascular Age-related Macular Degeneration With Anti-VEGF Agents</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Diagnosis neovascular agerelated macular degeneration Visual acuity well 20/400 Loading dose three intravitreal injection antiVEGF agent , administred one per month three month Followup period least six month Choroidal neovascularization secondary cause agerelated macular degeneration Eyes polypoidal choroidal vasculopathy Eyes previously submit posterior vitrectomy Other disease could affect visual acuity</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>